SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ELITE PHARMACEUTICALS INC
(NQBB:ELTP Last Sale: .1 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQBB: (ELTP : $.1)
$39 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today
Northvale, NJ Research Report Earnings Snapshot - Last 11/14/16
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders. The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.
Historical Charts    Technical Analysis
No Historical Data available for ELTP

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ELTP $.1 $ 0 $.084 $.104 8,447,231 $.0507 $.143 394,580
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $39,458

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex